Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Essential oils vs. chemo nerve pain: a natural remedy put to the test

NCT ID NCT07779135

Symptom relief Sponsor: Centre Hospitalier de Colmar Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 21, 2026 · Last updated Aug 21, 2026

Summary

This trial tests whether a topical blend of essential oils can reduce the painful, tingling, or numb sensations caused by chemotherapy-induced neuropathy in breast cancer patients treated with paclitaxel. The study enrolls women with bothersome nerve symptoms that standard medications haven't relieved. Researchers will track changes in sensory and pain symptoms using a specialized questionnaire, as well as overall quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A topical blend of essential oils applied to the skin
What this could lead to
If effective, this could offer a natural, drug-free option to help breast cancer patients manage painful nerve symptoms caused by chemotherapy.
What could go wrong
This is a small, early-stage study, and aromatherapy may not provide meaningful relief for everyone. Some people may also have skin reactions or allergies to essential oils.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2026

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Female patients with breast cancer attending at Colmar Hospital

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female patients with breast cancer * who have painful or bothersome CIN * occurring in the context of paclitaxel treatment (during or after treatment) * for whom conventional drug treatments provide insufficient relief (or are poorly tolerated or refused). * Age ≥ 18 years * Who, after receiving information, do not object to the use of their data for the purposes of this research Exclusion Criteria: * Pre-existing neuropathy (e.g., due to diabetes) * Known allergy to an essential oil or a component of essential oils (e.g., linalool) * Presence of wounds on the affected areas * Refusal to use aromatherapy * Inability to complete the questionnaires

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm chemotherapy-induced neuropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer Neuropathic pain in cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hôpitaux Civils de Colmar

    RECRUITING

    Colmar, 68024, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.